RxSight, Inc. (RXST) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $19.95M | +19.4% |
| 2024 | $16.71M | +72.4% |
| 2023 | $9.69M | -18.1% |
| 2022 | $11.83M | -51.4% |
| 2021 | $24.36M | +74.1% |
| 2020 | $13.99M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $19.95M | +19.4% |
| 2024 | $16.71M | +72.4% |
| 2023 | $9.69M | -18.1% |
| 2022 | $11.83M | -51.4% |
| 2021 | $24.36M | +74.1% |
| 2020 | $13.99M | — |